Author:
Kivitz Alan,Cohen Steven,Dowd James Edward,Edwards William,Thakker Suman,Wellborne Frank R.,Renz Cheryl L.,Segurado Oscar G.
Subject
Pharmacology (medical),Pharmacology
Reference19 articles.
1. HUMIRA (adalimumab),2006
2. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study;Weisman;Clin Ther,2003
3. A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2177) in patients with rheumatoid arthritis;den Broeder;J Rheumatol,2002
4. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial;Weinblatt;Arthritis Rheum,2003
5. Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study;Weinblatt;Ann Rheum Dis,2006
Cited by
120 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献